David S. Siegel, MD, PhD of John Theurer Cancer Center discusses the combination of pembrolizumab and lenalidomide for treating patients with multiple myeloma at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Is combining pembrolizumab and lenalidomide effective when managing multiple myeloma patients?
